U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

Originator

Curator's Comment: Ulex, a Swedish geologist, is generally credited with introduction of the term struvite in1845

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Primary
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Diagnostic
ColPrep Kit

Approved Use

INDICATIONS AND USAGE ColPrep Kit is indicated for cleansing of the colon as a preparation for colonoscopy in adults

Launch Date

2016
Primary
MAGNESIUM SULFATE

Approved Use

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Launch Date

1995
Curative
MagMin

Approved Use

Magnesium aspartate (MagMin) is indicated for patients with documented hypomagnesaemia.
Curative
DELBIASE

Approved Use

Unknown
Primary
DELBIASE

Approved Use

Unknown
Primary
DELBIASE

Approved Use

Unknown
Curative
Magnesium Chloride

Approved Use

Magnesium Chloride injection is indicated as an electrolyte replenisher in magnesium deficiencies
Palliative
Magnesium Chloride

Approved Use

Unknown
Palliative
Magnesium Chloride

Approved Use

Unknown
Primary
EPIMAG

Approved Use

Magnesium citrate is indicated in cases of oxaluria, to prevent recurrence of calcium oxalate kidney stones.
Primary
EPIMAG

Approved Use

Used to relief of occasional constipation (irregularity).
Curative
Magnesium Citrate

Approved Use

Magnesium citrate is indicated to supports magnesium nutritional adequacy.
Curative
Unknown

Approved Use

Magnesium lactate is a naturally occurring mineral that is needed in the body to support the function of the heart, nervous system, and digestive system. Magnesium lactate is used as a mineral supplement to treat magnesium deficiency.
PubMed

PubMed

TitleDatePubMed
Antenatal Exposure to Magnesium Sulfate and Spontaneous Intestinal Perforation and Necrotizing Enterocolitis in Extremely Preterm Neonates.
2017-10
Fast sono assisted ferrofluid mediated silver super - Adsorption over magnesium ferrite-copper sulfide chalcogenide with the aid of multivariate optimization.
2017-07
Effect of power ultrasound on crystallization characteristics of magnesium ammonium phosphate.
2017-05
Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes.
2017-03-01
Superiority of a Split-dose Regimen of Sodium Picosulfate/Magnesium Citrate (SPMC) in Comparison to a Prior-day Schedule (AM/PM) for Colonoscopy Preparation. A Randomized Single-blinded Study.
2016-09
Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.
2016-06-15
Polyethylene glycol plus ascorbic acid is as effective as sodium picosulfate with magnesium citrate for bowel preparation: A randomized trial.
2016-04
Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats.
2016
Single-day sodium picosulfate and magnesium citrate versus split-dose polyethylene glycol for bowel cleansing prior to colonoscopy: A prospective randomized endoscopist-blinded trial.
2015-11
Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate.
2015-02
A comparison of oral sulfate solution with sodium picosulfate: magnesium citrate in split doses as bowel preparation for colonoscopy.
2014-12
No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia.
2014-09-10
Precipitation of amorphous magnesium ammonium phosphate: is it a precursor for staghorn stones?
2014-06
Effects of three kinds of organic acids on phosphorus recovery by magnesium ammonium phosphate (MAP) crystallization from synthetic swine wastewater.
2014-04
[The effectiveness of certain magnesium salts in nephrolithiasis caused by the use of sodium oxalate and celecoxib].
2013-05-14
Effect of magnesium lactate dihydrate and calcium lactate monohydrate on 20-km cycling time trial performance.
2012-04
Magnesium chloride tetrahydrate, MgCl2·4H2O.
2012-01
Increased expression of glucose transporter 3 in gerbil brains following magnesium sulfate treatment and focal cerebral ischemic injury.
2010-06
Intradermal administration of magnesium sulphate and magnesium chloride produces hypesthesia to mechanical but hyperalgesia to heat stimuli in humans.
2009-08-28
Formation of formal disilene fluoride adducts.
2008-12-24
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
2006-04
Synthesis of a non-heme template for attaching four peptides: an approach to artificial iron(II)-containing peroxidases.
2004-01-23
Magnesium bromide mediated highly diastereoselective heterogeneous hydrogenation of olefins.
2002-04-18
Oral magnesium load test in patients with migraine.
2002-02
Bioavailability of US commercial magnesium preparations.
2001-12
Trifluoromethanesulfonic anhydride-promoted alpha-bromination of ketones with grignard reagent or magnesium bromide.
2000-12
An efficient chiral moderator prepared from inexpensive (+)-3-carene: synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963.
2000-10-05
Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes.
1999-11
Some magnesium salts and a mixture of magnesium and calcium salts accelerate skin barrier recovery.
1999-10
Struvite stones.
1999
Magnesium supplementation in patients with congestive heart failure.
1997-02
Conventional and Eccentric Uses of Crystallographic Databases in Practical Materials Identification Problems.
1996-01-01
Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride.
1995-03
Effect of pyridoxine and magnesium on stress-induced gastric ulcers in mice selected for low or high blood magnesium levels.
1995
Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity.
1995
A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
1994-12
Accidental cardiopulmonary arrest following magnesium sulphate overdose.
1994-06-15
Management of eclampsia.
1994-04
Oral versus intravenous magnesium supplementation in patients with magnesium deficiency.
1991-01-01
Magnesium and its combination with cinnarizine in the long-term treatment of headache.
1991
Osteoporosis treated with magnesium lactate.
1991
Fluorimetry of selenium in body fluids after digestion with nitric acid, magnesium nitrate hexahydrate, and hydrochloric acid.
1988-09
A comparison of two digestion procedures for the determination of selenium in biological material.
1987-10
Metabolism of magnesium and zinc in patients treated with antiepileptic drugs and with magnesium lactate.
1987
Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.
1986-11
Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides.
1986-03-22
[Inhibitory effect of magnesium on the vocalization and fighting of cats treated with carbachol and eserine].
1982
Cardiopulmonary arrest due to acute maternal hypermagnesaemia.
1981-05-09
Struvite stones.
1978-05
Metabolic effects of prolonged intravenous administration of magnesium lactate to the normal human.
1958-09-23
Patents

Patents

Sample Use Guides

Magnesium lactate is used as a dietary supplement (200-400 mg of elemental magnesium per day for adults).
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Magnesium Chloride
Unknown
Name Type Language
MAGNESIUM SULFATE, UNSPECIFIED
Preferred Name English
MAGNESIUM SULFATE, UNSPECIFIED FORM
Common Name English
MAGNESIUM SULFATE
GREEN BOOK   II   INCI   ORANGE BOOK   USP   VANDF   WHO-DD  
INCI  
Preferred Name English
MAGNESIUM SULPHATE
Common Name English
MAGNESIUM SULFATE [GREEN BOOK]
Common Name English
MAGNESIUM (AS SULFATE) [VANDF]
Common Name English
MAGNESIUM SULFATE [II]
Common Name English
MAGNESIUM SULFATE [USP-RS]
Common Name English
TIS-U-SOL COMPONENT MAGNESIUM SULFATE
Common Name English
MAGNESIUM SULFATE [USP IMPURITY]
Common Name English
MAGNESIUM SULPHATE, UNSPECIFIED
Common Name English
MAGNESIUM SULFATE [ORANGE BOOK]
Common Name English
MAGNESIUM SULFATE, UNSPECIFIED FORM [GREEN BOOK]
Common Name English
MAGNESIUM SULFATE [VANDF]
Common Name English
Magnesium sulfate [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-VATC QA12CC02
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
FDA ORPHAN DRUG 379212
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 05
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-VATC QV04CC02
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-VATC QB05XA05
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ATC D11AX05
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
CFR 21 CFR 184.1443
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
FDA ORPHAN DRUG 403513
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-VATC QA06AD04
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
CFR 21 CFR 522.380
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
EPA PESTICIDE CODE 50503
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-VATC QD11AX05
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ATC A06AD04
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
CFR 21 CFR 310.531
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ATC A12CC02
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ATC V04CC02
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
WHO-ATC B05XA05
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
FDA ORPHAN DRUG 616817
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
Code System Code Type Description
DRUG BANK
DB00653
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
CHEBI
32599
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
EVMPD
SUB14448MIG
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
ChEMBL
CHEMBL2021423
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
MESH
D008278
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
WIKIPEDIA
MAGNESIUM SULFATE
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
DRUG CENTRAL
4290
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
NCI_THESAURUS
C623
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
LACTMED
Magnesium Sulfate
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
DAILYMED
DE08037SAB
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
RXCUI
6585
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY RxNorm
FDA UNII
DE08037SAB
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 18:14:16 GMT 2025 , Edited by admin on Mon Mar 31 18:14:16 GMT 2025
CONCEPT Industrial Aid
Definition References